ABA 0.00% $5.15 abano healthcare group limited

Ann: RELINT: ABA: Ongoing Disclosure Notice - P.

  1. lightbulb Created with Sketch. 2
    • Release Date: 15/05/13 12:00
    • Summary: RELINT: ABA: Ongoing Disclosure Notice - P. Dunphy
    • Price Sensitive: No
    • Download Document  1.97KB
    					
    
    ABA
    15/05/2013 10:00
    RELINT
    
    REL: 1000 HRS Abano Healthcare Group Limited
    
    RELINT: ABA: Ongoing Disclosure Notice - P. Dunphy
    
    Ongoing Disclosure Notice
    Disclosure of Directors and Officers Relevant Interests
    Section 19T(2), Securities Markets Act 1988
    
    A Details of director or officer
    Name of director or officer of public issuer:  Philippa Jane Dunphy
    Name of public issuer: Abano Healthcare Group Limited
    Name of related body corporate (if applicable):  N/A
    Position held in public issuer:  Director
    
    B Securities in public issuer or related body corporate to which this
    disclosure relates
    Number, class, and type of securities: 1,928 ordinary shares (total holding
    of 2,992 ordinary shares after the transaction)
    
    C Nature of relevant interest and name of registered holder
    Nature of relevant interest in those securities:  Registered holder &
    beneficial owner
    Name of registered holder of those securities  Philippa Jane Dunphy
    
    D Details of acquisitions and disposals
    If the relevant interest was acquired--
    Date of acquisition:  10 May 2013
    Consideration paid for acquisition:   $10,970.32 (1,928 ordinary shares at
    $5.69 per share)
    
    If the relevant interest was disposed of--
    Date of disposal:   N/A
    Consideration received for disposal:   N/A
    
    Type of transaction
    Describe the arrangement pursuant to which, or the circumstances in which,
    the acquisition or disposal took place:   Purchase of Ordinary Shares through
    the market pursuant to the Directors Fixed Trading Share Plan
    
    E Total number of transactions this notice relates to:  1 transaction
    
    F Date of last disclosure notice (whether in form 1 or form 2) by the
    director or officer:   1 February 2013
    
    G Signature
    Signature of director or officer:
    Date of signature:
    or
    Signature of person authorised to sign on behalf of director or officer:
    Date of signature:  14 May 2013
    Name and title of authorised person:  "Richard Keys
    Chief Operating Officer / Chief Financial Officer"
    End CA:00236239 For:ABA    Type:RELINT     Time:2013-05-15 10:00:57
    				
 
watchlist Created with Sketch. Add ABA (NZSX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.